In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases

Arthritis and Rheumatism

Volumn 40, Issue 2, 1997, Pages 306-317

  Lorenz, Hanns Martin ^a   Grünke, Mathias ^a   Hieronymus, Thomas ^a   Herrmann, Martin ^a   Kühnel, Almuth ^a   Manger, Bernhard ^a   Kalden, Joachim R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYC PROTEIN; PROTEIN BCL 2;

AORTA ARCH SYNDROME; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; MONONUCLEAR CELL; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

APOPTOSIS; AUTOIMMUNE DISEASES; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; DNA-BINDING PROTEINS; FAS LIGAND PROTEIN; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIXED CONNECTIVE TISSUE DISEASE; POLYARTERITIS NODOSA; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; RNA, MESSENGER; TAKAYASU'S ARTERITIS; TRANSCRIPTION FACTORS; WEGENER GRANULOMATOSIS;

EID: 1842334483     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400216     Document Type: Article

References (61)

1. Watanabe-Fukunaga R, Brannan C, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274-1279, 1992
2. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-1 antigen, a new member of the TNF/NGF receptor superfamily: sequence identity with the Fas antigen. J Biol Chem 267:10709-10715, 1992
3. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins A, Nagata S: Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
4. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle LM, Seldin MF: Genetic analysis of MRL-lpr mice: relationship of the fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 176:1645-1656, 1992
5. Adachi M, Watanabe-Fukunaga R, Nagata S: Aberrant transcription caused by the insertion of an early transposable element in an intron of the fas antigen gene of lpr mice. Proc Natl Acad Sci U S A 90:1756-1760, 1993
6. Chu J-L, Drappa J, Paranassa A, Elkon KB: The defect in Fas mRNA expression in MLR/lpr mice is associated with insertion of the retrotransposon ETn. J Exp Med 178:723-730, 1993
7. Itoh N, Yonehara A, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
8. Rouvier E, Luciani MF, Golstein P: Fas involvement in Ca ++ independent T cell-mediated cytotoxicity. J Exp Med 177:195-200, 1993
9. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365-371, 1994
10. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugal T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effects of the anti-Fas antibody in mice. Nature 364:806-809, 1993
11. Reap EA, Leslie D, Abrahams M, Eisenberg RA, Cohen PL: Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J Immunol 154:936-943, 1995
12. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269, 1991
13. Russel JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci U S A 90:4409-4413, 1993
14. Bossu P, Singer GG, Andres P, Ettinger M, Marshak-Rothstein A, Abbas AK: Mature CD4+ T lymphocytes from MLR/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J Immunol 151:7233-7239, 1993
15. Gillette-Ferguson I, Sidman CL: A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur J Immunol 24:1181-1185, 1994
16. Nagata S, Suda T: Fas and Fas-ligand: lpr and gld mutations. Immunol Today 16:39-43, 1995
17. Wu J, Zhou T, Zhang J, He J, Gause WC, Mountz JD: Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci U S A 91:2344-2348, 1994
18. Allen RD, Marshall JD, Roths JB, Sidman CL: Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 172:1367-1375, 1990
19. Suda T, Takahashi T, Goldstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993
20. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879, 1994
21. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas-ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993
22. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas ligand: gene structure, chromosomal location and species specifity. Int Immunol 6:1567-1574, 1994
23. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976, 1994
24. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K: The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131-136, 1994
25. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH: Gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol 24:928-933, 1994
26. Strasser A, Wittingham S, Vaux DL, Bath ML, Adams JM, Corry S, Harris AW: Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A 88:8661-8665, 1991
27. Siegel RM, Katsumata M, Miyashita T, Kouie DC, Greene MI, Reed JC: Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci U S A 89:7003-7007, 1992
28. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ: Bcl-xL and bcl-2 repress a common pathway of cell death. J Exp Med 182:821-828, 1995
29. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888, 1991
30. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
31. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251, 1995
32. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367-377, 1995
33. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627, 1993
34. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, Elkon KB: The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 93:1029-1034, 1994
35. Kumagai S, Yanagida H, Tsujimoto Y: Increased expression of BCL2 protein in peripheral B cells of patients with systemic lupus erythematosus (abstract). Arthritis Rheum 36 (suppl 9):S76, 1993
36. Graninger WB: Transcriptional overexpression of the protooncogene bcl-2 in patients with systemic lupus erythematosus. Wien Klin Wochenschr 104:205-207, 1992
37. Rose LM, Latchman DS, Isenberg DA: Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Br J Rheumatol 340:3160-3200, 1995
38. Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685-3692, 1994
39. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317-1330, 1994
40. Savill J, Fadok V, Henson P, Haslett C: Phahocyte recognition of cells undergoing apoptosis. Immunol Today 14:131-136, 1993
41. Flora PK, Gregory CD: Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur J Immunol 24:2625-2632, 1994
42. Rosen A, Casciola-Rosen L, Ahearn J: Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 181:1557-1561, 1995
43. Boise LH, Gonzales-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993
44. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619, 1993
45. Ayer DE, Kretzner L, Eisenman RN: Mad: a heterodimeric partner for max that antagonizes myc transcriptional activity. Cell 72:211-222, 1993
46. Lahoz EG, Xu L, Schreiber-Agus N, DePinhp RA: Suppression of myc, but not E1a, transformation activity by max-associated proteins, mad and mxi-1. Proc Natl Acad Sci U S A 91:5503-5507, 1994
47. Blackwood EM, Eisenman RN: Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science 251:1211-1217, 1991
48. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H: Oncogenic activity of the c-myc protein requires dimerization with max. Cell 72:233-245, 1993
49. Bissonnette RP, McGahon A, Mahboubi A, Green DR: Func tional myc-max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J Exp Med 180:2413-2418, 1994
50. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR: Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214, 1992
51. Hermeking H, Eick D: mediation of c-myc-induced apoptosis by p53. Science 265:2091-2093, 1994
52. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed bcl-2 homologue bak. Nature 374:736-739, 1995
53. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the bcl-2 homologue bak. Nature 374:733-736, 1995
54. Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC, Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731-733, 1995
55. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
56. Lagoo-Deenadayalan S, Lagoo AS, Barber WH, Hardy KJ: A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res 12:59-67, 1993
57. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of bcl-xL. Immunity 3:87-98, 1995
58. Ohsako S, Hara M, Harigai M, Fukasawa C, Kashiwazaki S: Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 73:109-114, 1994
59. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946, 1995
60. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349, 1995
61. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB: High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 37:1423-1430, 1994